RECORNA Biotech is a fast-growing RNA editing therapy startup with operations headquartered in Guangzhou, China. We strive to deliver first-in-class innovative solutions (RNA editing ASO) to address unmet medical needs around the world.

OUR PLATFORM

Our foundational platform for RNA editing, MIMIC, harnesses the body’s natural base editing system to make targeted changes at the RNA level. MIMIC enables the modification of protein sequence and function without permanently modifying the genome, opening new opportunities to solve many of the challenges facing current day approaches and to cure previously untreatable diseases.

OUR AMBITION

A spectrum of projects/assets in genetic, metabolic, and oncologic diseases in the next few years.